{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:56:10Z","timestamp":1791021370736,"version":"4.1.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018554","name":"Science and Technology Program of Gansu Province","doi-asserted-by":"publisher","award":["ZX-62000002-2021-226"],"award-info":[{"award-number":["ZX-62000002-2021-226"]}],"id":[{"id":"10.13039\/501100018554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.livres.2026.08.003","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:30:11Z","timestamp":1788222611000},"page":"220-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of mesenchymal stem cells on the coagulation mechanism in patients with liver cirrhosis: A review and prospects"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5654-3632","authenticated-orcid":false,"given":"Wanyuan","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2026.08.003_bib1","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2026.08.003_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.livres.2024.08.001","article-title":"Outcome of bariatric surgery in patients with unexpected liver cirrhosis: a multicenter study from China","volume":"8","author":"Sun","year":"2024","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2026.08.003_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.livres.2024.05.004","article-title":"Hepatitis B virus as a risk factor for hepatocellular carcinoma","volume":"8","author":"Abdelhamed","year":"2024","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2026.08.003_bib4","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.livres.2026.08.003_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.08.003_bib6","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.livres.2026.08.003_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2478\/v10039-010-0018-3","article-title":"Coagulopathy in liver diseases","volume":"55","author":"Pluta","year":"2010","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.livres.2026.08.003_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jor.20023","article-title":"Nonadherent cell population of human marrow culture is a complementary source of mesenchymal stem cells (MSCs)","volume":"24","author":"Wan","year":"2006","journal-title":"J Orthop Res"},{"key":"10.1016\/j.livres.2026.08.003_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13287-016-0418-9","article-title":"Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta","volume":"7","author":"Du","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.livres.2026.08.003_bib10","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1097\/TA.0000000000001485","article-title":"Procoagulant activity of human mesenchymal stem cells","volume":"83","author":"Christy","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.livres.2026.08.003_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-2002-23205","article-title":"Coagulation disorders in liver disease","volume":"22","author":"Amitrano","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.livres.2026.08.003_bib12","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.jhep.2021.11.004","article-title":"Haemostatic alterations and management of haemostasis in patients with cirrhosis","volume":"76","author":"Lisman","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.08.003_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1582-4934.2009.00980.x","article-title":"The coagulation factor xa\/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm","volume":"14","author":"Borensztajn","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.livres.2026.08.003_bib14","doi-asserted-by":"crossref","first-page":"G171","DOI":"10.1152\/ajpgi.00402.2017","article-title":"Role of the blood coagulation cascade in hepatic fibrosis","volume":"315","author":"Pant","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2026.08.003_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2353\/ajpath.2008.070347","article-title":"Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation","volume":"172","author":"Borensztajn","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.livres.2026.08.003_bib16","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1093\/cvr\/cvac004","article-title":"Coagulation-independent effects of thrombin and factor Xa: role of protease-activated receptors in pulmonary hypertension","volume":"118","author":"Joseph","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.livres.2026.08.003_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/jth.13191","article-title":"Actions of thrombin in the interstitium","volume":"14","author":"de Ridder","year":"2016","journal-title":"J Thrombos Haemost"},{"key":"10.1016\/j.livres.2026.08.003_bib18","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/01.ATV.0000031340.68494.34","article-title":"Platelets and thrombin generation","volume":"22","author":"Monroe","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.livres.2026.08.003_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.05.006","article-title":"The central role of thrombin in bleeding disorders","volume":"38","author":"Negrier","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.livres.2026.08.003_bib20","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.3748\/wjg.v17.i45.5007","article-title":"Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation","volume":"17","author":"Maharshak","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2026.08.003_bib21","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/gut.52.8.1206","article-title":"Factor v leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection","volume":"52","author":"Wright","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.livres.2026.08.003_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"Coagulopathy of chronic liver disease","volume":"365","author":"Violi","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.livres.2026.08.003_bib23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0168-8278(02)00199-X","article-title":"Haemostatic abnormalities in patients with liver disease","volume":"37","author":"Lisman","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.08.003_bib24","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1055\/s-0029-1145259","article-title":"Hemostatic abnormalities and liver diseases","volume":"34","author":"Wada","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.livres.2026.08.003_bib25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1159\/000360514","article-title":"Coagulopathy in liver diseases: complication or therapy?","volume":"32","author":"Bianchini","year":"2014","journal-title":"Digestive Dis"},{"key":"10.1016\/j.livres.2026.08.003_bib26","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/jth.15052","article-title":"Anticoagulant and signaling functions of antithrombin","volume":"18","author":"Rezaie","year":"2020","journal-title":"J Thrombos Haemost"},{"key":"10.1016\/j.livres.2026.08.003_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/rth2.12456","article-title":"Carrier frequencies of antithrombin, protein C, and protein s deficiency variants estimated using a public database and expression experiments","volume":"5","author":"Maruyama","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.livres.2026.08.003_bib28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood-2018-07-818211","article-title":"The multifaceted role of fibrinogen in tissue injury and inflammation","volume":"133","author":"Luyendyk","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.livres.2026.08.003_bib29","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2006-08-040956","article-title":"Human plasma fibrinogen is synthesized in the liver","volume":"109","author":"Tennent","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.livres.2026.08.003_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.thromres.2018.04.005","article-title":"Structural changes of fibrinogen as a consequence of cirrhosis","volume":"166","author":"Gligorijevi\u0107","year":"2018","journal-title":"Thrombosis Res"},{"key":"10.1016\/j.livres.2026.08.003_bib31","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood.V61.6.1196.1196","article-title":"The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains","volume":"61","author":"Martinez","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.livres.2026.08.003_bib32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCRESAHA.117.310795","article-title":"Circulating platelets as mediators of immunity, inflammation, and thrombosis","volume":"122","author":"Koupenova","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.livres.2026.08.003_bib33","doi-asserted-by":"crossref","first-page":"643815","DOI":"10.3389\/fonc.2021.643815","article-title":"The provocative roles of platelets in liver disease and cancer","volume":"11","author":"Marie","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.livres.2026.08.003_bib34","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jhep.2008.03.009","article-title":"Thrombocytopenia associated with chronic liver disease","volume":"48","author":"Afdhal","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.08.003_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jth.15562","article-title":"Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: guidance from the SSC of the ISTH","volume":"20","author":"Roberts","year":"2022","journal-title":"J Thrombosis Haemostasis"},{"key":"10.1016\/j.livres.2026.08.003_bib36","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/liv.13317","article-title":"Thrombocytopenia in chronic liver disease","volume":"37","author":"Peck-Radosavljevic","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2026.08.003_bib37","first-page":"565","article-title":"Cellular localization of thrombopoietin mrna in the liver by in situ hybridization","volume":"25","author":"Nomura","year":"1997","journal-title":"Exp Hematol"},{"key":"10.1016\/j.livres.2026.08.003_bib38","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1182\/blood.V92.6.2189","article-title":"Primary role of the liver in thrombopoietin production shown by tissue-specific knockout","volume":"92","author":"Qian","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.livres.2026.08.003_bib39","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/hep.30561","article-title":"Lusutrombopag for the treatment of thrombocytopenia in patients with chronic liver disease undergoing invasive procedures (L-PLUS 2)","volume":"70","author":"Peck-Radosavljevic","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2026.08.003_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ejh.13342","article-title":"Transfusion strategies in patients with cirrhosis","volume":"104","author":"Liu","year":"2020","journal-title":"Eur J Haematology"},{"key":"10.1016\/j.livres.2026.08.003_bib41","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.3324\/haematol.2018.202309","article-title":"Fatal dysfunction and disintegration of thrombin-stimulated platelets","volume":"104","author":"Kim","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.livres.2026.08.003_bib42","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/09537104.2019.1624707","article-title":"Thrombin-induced platelet aggregation -effect of dabigatran using automated platelet aggregometry","volume":"31","author":"Shimizu","year":"2020","journal-title":"Platelets"},{"key":"10.1016\/j.livres.2026.08.003_bib43","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1007\/s00125-021-05498-0","article-title":"Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus","volume":"64","author":"Kohlmorgen","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.livres.2026.08.003_bib44","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cld.2008.07.002","article-title":"Immune interactions in hepatic fibrosis","volume":"12","author":"Holt","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.livres.2026.08.003_bib45","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1111\/jth.13147","article-title":"Platelet secretory behaviour: as diverse as the granules \u2026 or not?","volume":"13","author":"Heijnen","year":"2015","journal-title":"J Thrombosis and Haemostasis"},{"key":"10.1016\/j.livres.2026.08.003_bib46","article-title":"Immune function of endothelial cells: evolutionary aspects, molecular biology and role in atherogenesis","volume":"23:9770","author":"Kotlyarov","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2026.08.003_bib47","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nri2171","article-title":"Evolving functions of endothelial cells in inflammation","volume":"7","author":"Pober","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.livres.2026.08.003_bib48","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/cvr\/cvad076","article-title":"Endothelial mechanobiology in atherosclerosis","volume":"119","author":"Wang","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.livres.2026.08.003_bib49","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.3390\/ijms22158053","article-title":"Critical role of LSEC in post-hepatectomy liver regeneration and failure","volume":"22","author":"Maxime","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2026.08.003_bib50","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","article-title":"Liver sinusoidal endothelial cells: physiology and role in liver diseases","volume":"66","author":"Poisson","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.08.003_bib51","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/gut.2010.235689","article-title":"Von willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension","volume":"60","author":"Mura","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.livres.2026.08.003_bib52","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/hep.25806","article-title":"Von willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis","volume":"56","author":"Ferlitsch","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2026.08.003_bib53","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/apt.12564","article-title":"Von willebrand factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"39","author":"Maieron","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.livres.2026.08.003_bib54","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jhep.2016.06.002","article-title":"Von willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia","volume":"65","author":"Kalambokis","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.08.003_bib55","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2007.02.006","article-title":"Vascular endothelial dysfunction in cirrhosis","volume":"46","author":"Iwakiri","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2026.08.003_bib56","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7150\/thno.46360","article-title":"Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis","volume":"11","author":"Jiang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.livres.2026.08.003_bib57","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12072-018-9886-6","article-title":"Algorithms for managing coagulation disorders in liver disease","volume":"12","author":"Stravitz","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.livres.2026.08.003_bib58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13287-018-0972-4","article-title":"Progress in mesenchymal stem cell-based therapy for acute liver failure","volume":"9","author":"Wang","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.livres.2026.08.003_bib59","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s12072-021-10199-2","article-title":"Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial","volume":"15","author":"Shi","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.livres.2026.08.003_bib60","first-page":"8106818","article-title":"Mesenchymal stem cells: characteristics, function, and application","volume":"2019","author":"Li","year":"2019","journal-title":"Stem Cell Int"},{"key":"10.1016\/j.livres.2026.08.003_bib61","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13287-020-01690-y","article-title":"Comparative separation methods and biological characteristics of human placental and umbilical cord mesenchymal stem cells in serum-free culture conditions","volume":"11","author":"Yi","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.livres.2026.08.003_bib62","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1039\/D3LC00379E","article-title":"Scalable mesenchymal stem cell enrichment from bone marrow aspirate using deterministic lateral displacement (DLD) microfluidic sorting","volume":"23","author":"Zen","year":"2023","journal-title":"Lab Chip"},{"key":"10.1016\/j.livres.2026.08.003_bib63","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s13287-023-03587-y","article-title":"The heterogeneity of mesenchymal stem cells: an important issue to be addressed in cell therapy","volume":"14","author":"Li","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.livres.2026.08.003_bib64","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13287-020-01697-5","article-title":"Bone marrow-derived from the human femoral shaft as a new source of mesenchymal stem\/stromal cells: an alternative cell material for banking and clinical transplantation","volume":"11","author":"Drela","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.livres.2026.08.003_bib65","article-title":"Interactions of mesenchymal stromal\/stem cells and immune cells following MSC-based therapeutic approaches in rheumatoid arthritis","volume":"393\u2013394:104771","author":"Dehnavi","year":"2023","journal-title":"Cell Immunol"},{"key":"10.1016\/j.livres.2026.08.003_bib66","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/JLB.3MR0321-766R","article-title":"Immunomodulatory functions of oral mesenchymal stem cells: novel force for tissue regeneration and disease therapy","volume":"110","author":"Shang","year":"2021","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.livres.2026.08.003_bib67","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/biom11081074","article-title":"Micrornas and stem-like properties: the complex regulation underlying stemness maintenance and cancer development","volume":"11","author":"Divisato","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.livres.2026.08.003_bib68","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1007\/s00018-019-03125-1","article-title":"Biological functions of mesenchymal stem cells and clinical implications","volume":"76","author":"Naji","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.livres.2026.08.003_bib69","first-page":"1753","article-title":"Pre-treatment with bone marrow-derived mesenchymal stem cells inhibits systemic intravascular coagulation and attenuates organ dysfunction in lipopolysaccharide-induced disseminated intravascular coagulation rat model","volume":"125","author":"Wang","year":"2012","journal-title":"Chin Med J"},{"key":"10.1016\/j.livres.2026.08.003_bib70","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/07853890.2016.1157725","article-title":"Administration of bone marrow stromal cells in sepsis attenuates sepsis-related coagulopathy","volume":"48","author":"Tan","year":"2016","journal-title":"Ann Med"},{"key":"10.1016\/j.livres.2026.08.003_bib71","first-page":"830","article-title":"[Role of HMGB1-RAGE\/TLRs-NF-\u03baB signaling pathway on bone mesenchymal stem cells transplantation therapy for lipopolysaccaride-induced coagulation disorder rats]","volume":"30","author":"Xiu","year":"2018","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"10.1016\/j.livres.2026.08.003_bib72","doi-asserted-by":"crossref","first-page":"238","DOI":"10.14218\/JCTH.2019.00008","article-title":"Effect of autologous bone marrow stem cell therapy in patients with liver cirrhosis: a meta-analysis","volume":"7","author":"Wu","year":"2019","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.livres.2026.08.003_bib73","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1194\/jlr.R087411","article-title":"Membrane lipids define small extracellular vesicle subtypes secreted by mesenchymal stromal cells","volume":"60","author":"Lai","year":"2019","journal-title":"J Lipid Res"},{"key":"10.1016\/j.livres.2026.08.003_bib74","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.thromres.2014.03.022","article-title":"Differential roles of tissue factor and phosphatidylserine in activation of coagulation","volume":"133","author":"Spronk","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.livres.2026.08.003_bib75","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood.V78.7.1753.1753","article-title":"Platelet activation by immobilized monoclonal antibody: evidence for a CD9 proximal signal","volume":"78","author":"Griffith","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.livres.2026.08.003_bib76","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.thromres.2009.07.005","article-title":"Palmitoylation supports the association of tetraspanin CD63 with CD9 and integrin alphaiibbeta3 in activated platelets","volume":"125","author":"Israels","year":"2010","journal-title":"Thrombosis Res"},{"key":"10.1016\/j.livres.2026.08.003_bib77","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1182\/blood-2011-03-343061","article-title":"Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4","volume":"118","author":"Semeraro","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.livres.2026.08.003_bib78","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood-2016-03-707679","article-title":"Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va","volume":"128","author":"Deguchi","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.livres.2026.08.003_bib79","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/cells8030258","article-title":"Effect of mscs and MSC-derived extracellular vesicles on human blood coagulation","volume":"8","author":"Silachev","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.livres.2026.08.003_bib80","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.biocel.2018.05.008","article-title":"Adipose-derived mesenchymal stem cells release microvesicles with procoagulant activity","volume":"100","author":"Fiedler","year":"2018","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.livres.2026.08.003_bib81","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/stem.2891","article-title":"Intravenous infusion of human adipose mesenchymal stem cells modifies the host response to lipopolysaccharide in humans: a randomized, single-blind, parallel group, placebo controlled trial","volume":"36","author":"Perlee","year":"2018","journal-title":"Stem Cell"},{"key":"10.1016\/j.livres.2026.08.003_bib82","first-page":"1","article-title":"Advances in placenta-derived stem cells","volume":"10","author":"Liu","year":"2018","journal-title":"Chin J Prenat Diagn (Electr Vers)"},{"key":"10.1016\/j.livres.2026.08.003_bib83","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1089\/scd.2015.0120","article-title":"Different procoagulant activity of therapeutic mesenchymal stromal cells derived from bone marrow and placental decidua","volume":"24","author":"Moll","year":"2015","journal-title":"Stem Cell Dev"},{"key":"10.1016\/j.livres.2026.08.003_bib84","first-page":"1658195","article-title":"Human placenta-derived mesenchymal stem cells reduce mortality and hematoma size in a rat intracerebral hemorrhage model in an acute phase","volume":"2018","author":"Choi","year":"2018","journal-title":"Stem Cell Int"},{"key":"10.1016\/j.livres.2026.08.003_bib85","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13287-018-0936-8","article-title":"Human mesenchymal stromal cells inhibit platelet activation and aggregation involving CD73-converted adenosine","volume":"9","author":"Netsch","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.livres.2026.08.003_bib86","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41392-025-02318-4","article-title":"Dose-escalation studies of mesenchymal stromal cell therapy for decompensated liver cirrhosis: phase ia\/ib results and immune modulation insights","volume":"10","author":"Shi","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.livres.2026.08.003_bib87","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13287-020-01655-1","article-title":"Ultrasound-targeted microbubble destruction optimized HGF-overexpressing bone marrow stem cells to repair fibrotic liver in rats","volume":"11","author":"Sun","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.livres.2026.08.003_bib88","first-page":"81","article-title":"Transplant of hepatocytes, undifferentiated mesenchymal stem cells, and in vitro hepatocyte-differentiated mesenchymal stem cells in a chronic liver failure experimental model: a comparative study","volume":"16","author":"Baz","year":"2018","journal-title":"Exp Clin Transplantion"},{"key":"10.1016\/j.livres.2026.08.003_bib89","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/14653241003596661","article-title":"No contribution of umbilical cord mesenchymal stromal cells to capillarization and venularization of hepatic sinusoids accompanied by hepatic differentiation in carbon tetrachloride-induced mouse liver fibrosis","volume":"12","author":"Ren","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/j.livres.2026.08.003_bib90","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s13287-020-01852-y","article-title":"Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis","volume":"11","author":"Xiang","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.livres.2026.08.003_bib91","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jvn.2021.07.006","article-title":"Case study: acute iliofemoral DVT in a young female with factor V leiden","volume":"39","author":"Green","year":"2021","journal-title":"J Vasc Nurs"},{"key":"10.1016\/j.livres.2026.08.003_bib92","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13287-015-0106-1","article-title":"The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency","volume":"6","author":"Zekri","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.livres.2026.08.003_bib93","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13287-023-03323-6","article-title":"Therapeutic potential of mscs and MSC-derived extracellular vesicles in immune thrombocytopenia","volume":"14","author":"Wu","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.livres.2026.08.003_bib94","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.livres.2024.11.004","article-title":"Application of mesenchymal stem cells in liver fibrosis and regeneration","volume":"8","author":"Liu","year":"2024","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2026.08.003_bib95","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12272-012-0202-z","article-title":"Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications","volume":"35","author":"Yi","year":"2012","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.livres.2026.08.003_bib96","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12967-016-0792-1","article-title":"Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively","volume":"14","author":"Huang","year":"2016","journal-title":"J Transl Med"},{"key":"10.1016\/j.livres.2026.08.003_bib97","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.3748\/wjg.v11.i29.4497","article-title":"Liver-specific gene expression in mesenchymal stem cells is induced by liver cells","volume":"11","author":"Lange","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2026.08.003_bib98","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5009\/gnl18412","article-title":"Mesenchymal stem cells for the treatment of liver disease: present and perspectives","volume":"14","author":"Kang","year":"2020","journal-title":"Gut Liver"},{"key":"10.1016\/j.livres.2026.08.003_bib99","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1172\/JCI0215182","article-title":"Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells","volume":"109","author":"Schwartz","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.livres.2026.08.003_bib100","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/cbin.11725","article-title":"The role of mesenchymal stem cells in liver injury","volume":"46","author":"Sun","year":"2022","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.livres.2026.08.003_bib101","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41419-022-04708-w","article-title":"Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury","volume":"13","author":"Lin","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.livres.2026.08.003_bib102","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13287-022-03010-y","article-title":"Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering mir-148a to target KLF6\/STAT3 pathway in macrophages","volume":"13","author":"Tian","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.livres.2026.08.003_bib103","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13287-023-03494-2","article-title":"Meta-analysis on last ten years of clinical injection of bone marrow-derived and umbilical cord MSC to reverse cirrhosis or rescue patients with acute-on-chronic liver failure","volume":"14","author":"Wang","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.livres.2026.08.003_bib104","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12712","article-title":"Immune modulation by mesenchymal stem cells","volume":"53","author":"Jiang","year":"2020","journal-title":"Cell Prolif"},{"key":"10.1016\/j.livres.2026.08.003_bib105","article-title":"Extracellular vesicles derived from mesenchymal stromal cells as nanotherapeutics for liver ischaemia-reperfusion injury by transferring mitochondria to modulate the formation of neutrophil extracellular traps","volume":"284: 121486","author":"Lu","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.livres.2026.08.003_bib106","doi-asserted-by":"crossref","first-page":"404","DOI":"10.15283\/ijsc20052","article-title":"Upregulation of C-Reactive protein by placenta-derived mesenchymal stem cells promotes angiogenesis in a rat model with cirrhotic liver","volume":"13","author":"Jun","year":"2020","journal-title":"Int J Stem Cells"},{"key":"10.1016\/j.livres.2026.08.003_bib107","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s12951-022-01636-x","article-title":"Huc-MSC-derived exosomes modified with the targeting peptide of ahscs for liver fibrosis therapy","volume":"20","author":"Lin","year":"2022","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.livres.2026.08.003_bib108","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/scrt459","article-title":"Peripheral vein infusion of autologous mesenchymal stem cells in egyptian HCV-positive patients with end-stage liver disease","volume":"5","author":"Salama","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.livres.2026.08.003_bib109","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MEG.0b013e32832eb69a","article-title":"Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study","volume":"22","author":"Lyra","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.08.003_bib110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.21037\/sci.2018.07.04","article-title":"Haemostatic potential of human bone marrow-derived mesenchymal stromal cells in wistar rats with carbon tetrachloride induced liver cirrhosis","volume":"5","author":"Aithal","year":"2018","journal-title":"Stem Cell Investig"},{"key":"10.1016\/j.livres.2026.08.003_bib111","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/hep.28693","article-title":"Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: phase 2 trial","volume":"64","author":"Suk","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2026.08.003_bib112","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1440-1746.2011.07024.x","article-title":"Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients","volume":"27","author":"Zhang","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.08.003_bib113","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/jgh.14081","article-title":"A study about immunomodulatory effect and efficacy and prognosis of human umbilical cord mesenchymal stem cells in patients with chronic hepatitis B-induced decompensated liver cirrhosis","volume":"33","author":"Fang","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.08.003_bib114","doi-asserted-by":"crossref","first-page":"e13287","DOI":"10.1097\/MD.0000000000013287","article-title":"Cord-derived mesenchymal stem cells therapy for liver cirrhosis in children with refractory Henoch-Schonlein purpura: a case report","volume":"97","author":"Mu","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.livres.2026.08.003_bib115","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3349\/ymj.2013.54.5.1293","article-title":"Familial occurrence of pulmonary embolism after intravenous, adipose tissue-derived stem cell therapy","volume":"54","author":"Jung","year":"2013","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.livres.2026.08.003_bib116","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bbrc.2012.12.134","article-title":"Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism","volume":"431","author":"Tatsumi","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.livres.2026.08.003_bib117","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13287-020-1572-7","article-title":"Infusion-related thrombogenesis by liver-derived mesenchymal stem cells controlled by anticoagulant drugs in 11 patients with liver-based metabolic disorders","volume":"11","author":"Coppin","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.livres.2026.08.003_bib118","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/stcltm\/szab005","article-title":"Improved MSC minimal criteria to maximize patient safety: a call to embrace tissue factor and hemocompatibility assessment of MSC products","volume":"11","author":"Moll","year":"2022","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.livres.2026.08.003_bib119","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.tcm.2015.12.001","article-title":"Tissue factor as a link between inflammation and coagulation","volume":"26","author":"Witkowski","year":"2016","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.livres.2026.08.003_bib120","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJMra0801082","article-title":"Mechanisms of thrombus formation","volume":"359","author":"Furie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.livres.2026.08.003_bib121","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.3390\/cells8101160","article-title":"Thrombogenic risk induced by intravascular mesenchymal stem cell therapy: current status and future perspectives","volume":"8","author":"Coppin","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.livres.2026.08.003_bib122","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/stem.1111","article-title":"Are therapeutic human mesenchymal stromal cells compatible with human blood?","volume":"30","author":"Moll","year":"2012","journal-title":"Stem Cell"},{"key":"10.1016\/j.livres.2026.08.003_bib123","article-title":"Comparative proteomic analysis of extracellular vesicles isolated from porcine adipose tissue-derived mesenchymal stem\/stromal cells","volume":"6:36120","author":"Eirin","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2026.08.003_bib124","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMra2104091","article-title":"Heparin resistance - clinical perspectives and management strategies","volume":"385","author":"Levy","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568426000437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568426000437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:11:19Z","timestamp":1791018679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568426000437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":124,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2542568426000437"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2026.08.003","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of mesenchymal stem cells on the coagulation mechanism in patients with liver cirrhosis: A review and prospects","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2026.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}